An adaptive approach to an evolving drug safety environment
Co-developed by the pharmaceutical industry group and the firm's Health Research Institute, this report is a focused analysis of the current state of drug safety monitoring (known as pharmacovigilance) and a guide to field-tested operational strategies that can be employed to improve current pharmacovigilance practices.